Hangzhou Coco Healthcare Products Co.Ltd. (SHE:301009) — Market Cap & Net Worth
Market Cap & Net Worth: Hangzhou Coco Healthcare Products Co.Ltd. (301009)
Hangzhou Coco Healthcare Products Co.Ltd. (SHE:301009) has a market capitalization of $449.53 Million (CN¥3.07 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #13104 globally and #4117 in its home market, demonstrating a -3.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hangzhou Coco Healthcare Products Co.Ltd.'s stock price CN¥11.30 by its total outstanding shares 271860000 (271.86 Million). Analyse Hangzhou Coco Healthcare Products Co.Ltd (301009) cash flow conversion to see how efficiently the company converts income to cash.
Hangzhou Coco Healthcare Products Co.Ltd. Market Cap History: 2021 to 2026
Hangzhou Coco Healthcare Products Co.Ltd.'s market capitalization history from 2021 to 2026. Data shows change from $722.29 Million to $449.53 Million (-15.34% CAGR).
Hangzhou Coco Healthcare Products Co.Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hangzhou Coco Healthcare Products Co.Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.39x
Hangzhou Coco Healthcare Products Co.Ltd.'s market cap is 0.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.64x
Hangzhou Coco Healthcare Products Co.Ltd.'s market cap is 13.64 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $722.29 Million | $1.19 Billion | $39.75 Million | 0.61x | 18.17x |
| 2022 | $472.47 Million | $1.19 Billion | -$43.13 Million | 0.40x | N/A |
| 2023 | $419.71 Million | $1.08 Billion | $20.18 Million | 0.39x | 20.79x |
| 2024 | $425.27 Million | $1.08 Billion | $31.17 Million | 0.39x | 13.64x |
Competitor Companies of 301009 by Market Capitalization
Companies near Hangzhou Coco Healthcare Products Co.Ltd. in the global market cap rankings as of May 4, 2026.
Key companies related to Hangzhou Coco Healthcare Products Co.Ltd. by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #41 globally with a market cap of $344.11 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #95 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- L’Oreal SA (PA:OR): Ranked #104 globally with a market cap of $198.75 Billion USD ( €170.01 Billion EUR).
- Colgate-Palmolive Company (NYSE:CL): Ranked #382 globally with a market cap of $70.34 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #41 | Procter & Gamble Company | NYSE:PG | $344.11 Billion | $147.26 |
| #95 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #104 | L’Oreal SA | PA:OR | $198.75 Billion | €366.05 |
| #382 | Colgate-Palmolive Company | NYSE:CL | $70.34 Billion | $87.26 |
Hangzhou Coco Healthcare Products Co.Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Hangzhou Coco Healthcare Products Co.Ltd.'s market cap moved from $722.29 Million to $ 449.53 Million, with a yearly change of -15.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥449.53 Million | -10.88% |
| 2025 | CN¥504.43 Million | +18.62% |
| 2024 | CN¥425.27 Million | +1.32% |
| 2023 | CN¥419.71 Million | -11.17% |
| 2022 | CN¥472.47 Million | -34.59% |
| 2021 | CN¥722.29 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Hangzhou Coco Healthcare Products Co.Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $449.53 Million USD |
| MoneyControl | $449.53 Million USD |
| MarketWatch | $449.53 Million USD |
| marketcap.company | $449.53 Million USD |
| Reuters | $449.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hangzhou Coco Healthcare Products Co.Ltd.
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as feminine, cleaning, famil… Read more